Stay updated on Neoadj Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Neoadj Pembrolizumab Clinical Trial page.

Latest updates to the Neoadj Pembrolizumab Clinical Trial page
- Check4 days agoChange DetectedAdded a Locations section with Minnesota, New Hampshire, and North Carolina. Removed the HHS Vulnerability Disclosure link and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedA note was added clarifying that publications listed are automatically filled from PubMed and may not all pertain to the study, and the Revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved the government funding lapse disclaimer from the page; the study details now appear without that notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedNo substantial updates were observed to the study details, eligibility criteria, or outcomes; the content and structure remain the same, with only minor visual adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference3%

- Check90 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Neoadj Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj Pembrolizumab Clinical Trial page.